In 2018 the popular weight loss program changed its name to WW with an updated mission: Wellness That Works. For the first time, that mission includes medications
However, a different team found that both GLP-1 receptor agonists and SGLT2 inhibitors lowered the risk for Alzheimers disease and related dementias compared with second-line GLDs
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP1 and amylin analogues for weight management
PubMed, Geraedts, Maartje C
apply directly on their websites Compounding pharmacies compounded semaglutide and tirzepatide have been available at lower prices, though FDA has signaled changing policies on compound availability Community health centers (FQHCs) can assist with navigating access options and may offer sliding-scale care related to the underlying conditions Frequently Asked Questions Does Medicaid cover Ozempic
Ongoing Monitoring & Follow-Ups Regular check-ins to track progress, adjust dosing, and support long-term success
